glp 1 agonists approved for weight loss Comparing GLP-type therapies in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 agonists are part of
Description
Finck, B
Guzman-Perez, A
This means their quality, purity, and efficacy are not held to the same standards as licensed pharmaceuticals
The prescribing information also includes a boxed warning for thyroid C-cell tumors and several other important precautions
Limited Alternatives: There are few pharmaceutical options specifically targeting PCOS-related weight gain, making GLP-1 agonists an attractive option for many
In addition to your medication costs, you will pay a $199 monthly membership fee
